UB Paderborn / Katalog / Suche / in CDI

Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial

JAMA oncology, 2018-04, Vol.4 (4), p.495

2018

Volltextzugriff (PDF)

Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma

Clinical cancer research, 2016-08, Vol.22 (15), p.3860-3875

2016

Volltextzugriff (PDF)

Association between cytoplasmic CRABP2, altered retinoic acid signaling, and poor prognosis in glioblastoma

Glia, 2016-06, Vol.64 (6), p.963-976

2016

Volltextzugriff (PDF)

Phase II study of PX-866 in recurrent glioblastoma

Neuro-oncology (Charlottesville, Va.), 2015-09, Vol.17 (9), p.1270-1274

2015

Volltextzugriff (PDF)

Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study

Journal of clinical oncology, 2010-04, Vol.28 (12), p.2051-2057

2010

Volltextzugriff (PDF)

ClotAssist: A program to treat cancer-associated thrombosis in an outpatient pharmacy setting

Journal of oncology pharmacy practice, 2019-06, Vol.25 (4), p.818-823

2019

Volltextzugriff (PDF)

Stationary-to-migratory transition in glioblastoma stem-like cells driven by a fatty acid-binding protein 7-RXRα neurogenic pathway

Neuro-oncology (Charlottesville, Va.), 2023-12, Vol.25 (12), p.2177-2190

2023

Volltextzugriff (PDF)

How well do European patients understand cancer-associated thrombosis? A patient survey

Cancer treatment and research communications, 2022, Vol.31, p.100557-100557, Article 100557

2022

Volltextzugriff (PDF)

Community-based exercise for health promotion and secondary cancer prevention in Canada: protocol for a hybrid effectiveness-implementation study

BMJ open, 2019-09, Vol.9 (9), p.e029975-e029975

2019

Volltextzugriff (PDF)

Oncology Patients' Experiences With Novel Electronic Patient Portals to Support Care and Treatment: Qualitative Study With Early Users and Nonusers of Portals in Alberta, Canada

JMIR cancer, 2021-11, Vol.7 (4), p.e32609-e32609

2021

Volltextzugriff (PDF)

Management of recurrent medulloblastoma in adult patients: a systematic review and recommendations

Journal of neuro-oncology, 2013-10, Vol.115 (1), p.1-8

2013

Volltextzugriff (PDF)

Right Ventricular Normal Measurements: Time to Index?

Journal of the American Society of Echocardiography, 2012-12, Vol.25 (12), p.1259-1267

2012

Volltextzugriff (PDF)

Extended adjuvant temozolomide for treatment of newly diagnosed glioblastoma multiforme

Journal of neuro-oncology, 2012-05, Vol.108 (1), p.173-177

2012

Volltextzugriff (PDF)

phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation

Cancer chemotherapy and pharmacology, 2010-01, Vol.65 (2), p.353-361

2010

Volltextzugriff (PDF)

Accuracy of Resting Energy Expenditure Predictive Equations in Patients With Cancer

Nutrition in clinical practice, 2019-12, Vol.34 (6), p.922-934

2019

Volltextzugriff (PDF)

62 Improvement of hearing with bevacizumab in a patient with neurofibromatosis type 2 and bilateral acoustic schwannomas

Canadian journal of neurological sciences, 2018-06, Vol.45 (S3), p.S11-S11

2018

Volltextzugriff (PDF)

Feasibility of Implementing Cancer-Specific Community-Based Exercise Programming: A Multi-Centre Randomized Trial

Cancers, 2022-05, Vol.14 (11), p.2737

2022

Volltextzugriff (PDF)

Aggressive Childhood-onset Papillary Craniopharyngioma Managed With Vemurafenib, a BRAF Inhibitor

Journal of the Endocrine Society, 2021-05, Vol.5 (5), p.bvab043

2021

Volltextzugriff (PDF)

Determination of the methylation status of MGMT in different regions within glioblastoma multiforme

Journal of neuro-oncology, 2011-04, Vol.102 (2), p.255-260

2011

Volltextzugriff (PDF)

Evaluation of laboratory disturbance risk when adding low-dose cotrimoxazole for PJP prophylaxis to regimens of high-grade glioma patients taking RAAS inhibitors

Journal of oncology pharmacy practice, 2019-09, Vol.25 (6), p.1366-1373

2019

Volltextzugriff (PDF)

ACE-Neuro: A tailored exercise oncology program for neuro-oncology patients – Study protocol

Contemporary clinical trials communications, 2022-08, Vol.28, p.100925-100925, Article 100925

2022

Volltextzugriff (PDF)

Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme

Journal of neuro-oncology, 2008-08, Vol.89 (1), p.97-103

2008

Volltextzugriff (PDF)

Feasibility of performance‐based functional assessment in brain tumour survivors

European journal of cancer care, 2020-07, Vol.29 (4), p.e13238-n/a

2020

Volltextzugriff (PDF)

Lipidized glioblastoma: Pathological and molecular characteristics

Neuropathology, 2013-02, Vol.33 (1), p.87-92

2013

Volltextzugriff (PDF)

Economic analysis of bevacizumab, cetuximab, and panitumumab with fluoropyrimidine-based chemotherapy in the first-line treatment of KRAS wild-type metastatic colorectal cancer (mCRC)

Journal of medical economics, 2013-12, Vol.16 (12), p.1387-1398

2013

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial

Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma

Association between cytoplasmic CRABP2, altered retinoic acid signaling, and poor prognosis in glioblastoma

Phase II study of PX-866 in recurrent glioblastoma

Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study

ClotAssist: A program to treat cancer-associated thrombosis in an outpatient pharmacy setting

Stationary-to-migratory transition in glioblastoma stem-like cells driven by a fatty acid-binding protein 7-RXRα neurogenic pathway

How well do European patients understand cancer-associated thrombosis? A patient survey

Community-based exercise for health promotion and secondary cancer prevention in Canada: protocol for a hybrid effectiveness-implementation study

Oncology Patients' Experiences With Novel Electronic Patient Portals to Support Care and Treatment: Qualitative Study With Early Users and Nonusers of Portals in Alberta, Canada

Management of recurrent medulloblastoma in adult patients: a systematic review and recommendations

Right Ventricular Normal Measurements: Time to Index?

Extended adjuvant temozolomide for treatment of newly diagnosed glioblastoma multiforme

phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation

Accuracy of Resting Energy Expenditure Predictive Equations in Patients With Cancer

62 Improvement of hearing with bevacizumab in a patient with neurofibromatosis type 2 and bilateral acoustic schwannomas

Feasibility of Implementing Cancer-Specific Community-Based Exercise Programming: A Multi-Centre Randomized Trial

Aggressive Childhood-onset Papillary Craniopharyngioma Managed With Vemurafenib, a BRAF Inhibitor

Determination of the methylation status of MGMT in different regions within glioblastoma multiforme

Evaluation of laboratory disturbance risk when adding low-dose cotrimoxazole for PJP prophylaxis to regimens of high-grade glioma patients taking RAAS inhibitors

ACE-Neuro: A tailored exercise oncology program for neuro-oncology patients – Study protocol

Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme

Feasibility of performance‐based functional assessment in brain tumour survivors

Lipidized glioblastoma: Pathological and molecular characteristics

Economic analysis of bevacizumab, cetuximab, and panitumumab with fluoropyrimidine-based chemotherapy in the first-line treatment of KRAS wild-type metastatic colorectal cancer (mCRC)

Suchergebnisse filtern